1. Home
  2. LGND vs CXM Comparison

LGND vs CXM Comparison

Compare LGND & CXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • CXM
  • Stock Information
  • Founded
  • LGND 1987
  • CXM 2009
  • Country
  • LGND United States
  • CXM United States
  • Employees
  • LGND N/A
  • CXM N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • CXM Computer Software: Prepackaged Software
  • Sector
  • LGND Health Care
  • CXM Technology
  • Exchange
  • LGND Nasdaq
  • CXM Nasdaq
  • Market Cap
  • LGND 2.3B
  • CXM 2.3B
  • IPO Year
  • LGND 1992
  • CXM 2021
  • Fundamental
  • Price
  • LGND $120.43
  • CXM $9.30
  • Analyst Decision
  • LGND Strong Buy
  • CXM Hold
  • Analyst Count
  • LGND 6
  • CXM 15
  • Target Price
  • LGND $145.00
  • CXM $9.89
  • AVG Volume (30 Days)
  • LGND 107.6K
  • CXM 3.0M
  • Earning Date
  • LGND 11-07-2024
  • CXM 12-04-2024
  • Dividend Yield
  • LGND N/A
  • CXM N/A
  • EPS Growth
  • LGND 160.46
  • CXM 36.57
  • EPS
  • LGND 2.47
  • CXM 0.15
  • Revenue
  • LGND $152,422,000.00
  • CXM $788,062,000.00
  • Revenue This Year
  • LGND $26.86
  • CXM $8.44
  • Revenue Next Year
  • LGND $13.16
  • CXM $4.31
  • P/E Ratio
  • LGND $48.80
  • CXM $61.43
  • Revenue Growth
  • LGND N/A
  • CXM 12.02
  • 52 Week Low
  • LGND $67.53
  • CXM $6.91
  • 52 Week High
  • LGND $129.90
  • CXM $14.32
  • Technical
  • Relative Strength Index (RSI)
  • LGND 52.94
  • CXM 67.19
  • Support Level
  • LGND $113.39
  • CXM $8.81
  • Resistance Level
  • LGND $124.03
  • CXM $9.49
  • Average True Range (ATR)
  • LGND 5.31
  • CXM 0.37
  • MACD
  • LGND -0.50
  • CXM 0.06
  • Stochastic Oscillator
  • LGND 48.65
  • CXM 86.83

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About CXM Sprinklr Inc.

Sprinklr Inc is engaged in providing enterprise software that enables every customer-facing function across the front office, from Customer Care to Marketing, to collaborate across internal silos, and communicate across digital channels. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights and Sprinklr Marketing. The company operates in Americas, EMEA and other countries. It derives maximum revenue from Americas.

Share on Social Networks: